tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

IMAB Stock Latest News

I-Mab Biopharma’s Strategic Shift to US-Based Biotech
Company AnnouncementsI-Mab Biopharma’s Strategic Shift to US-Based Biotech
18d ago
6K
IMAB
I-Mab’s Third Quarter Results: Progress in Cancer Immunotherapies
PremiumCompany Announcements
I-Mab’s Third Quarter Results: Progress in Cancer Immunotherapies
1M ago
IMAB
I-Mab’s Promising Q3 Results and Strategic Moves
PremiumCompany Announcements
I-Mab’s Promising Q3 Results and Strategic Moves
1M ago
6K
IMAB
I-Mab reports Q3 EPS (25c) vs. (39c) last year
PremiumThe Fly
I-Mab reports Q3 EPS (25c) vs. (39c) last year
1M ago
IMAB
I-Mab Appoints New CEO to Drive Cancer Therapy Goals
PremiumCompany Announcements
I-Mab Appoints New CEO to Drive Cancer Therapy Goals
2M ago
6K
IMAB
I-Mab names Sean Fu as permanent CEO
PremiumThe FlyI-Mab names Sean Fu as permanent CEO
2M ago
IMAB
Inhibrx prevails in trade secret case with I-Mab
Premium
The Fly
Inhibrx prevails in trade secret case with I-Mab
2M ago
IMAB
INBX
I-Mab Biopharma’s Strategic US Transition and Pipeline Focus
Premium
Company Announcements
I-Mab Biopharma’s Strategic US Transition and Pipeline Focus
2M ago
6K
IMAB
I-MAB Appoints New Board Member and Audit Committee
PremiumCompany Announcements
I-MAB Appoints New Board Member and Audit Committee
3M ago
6K
IMAB
Closing Bell Movers: Intel jumps 9% on chip pact with Amazon
PremiumThe Fly
Closing Bell Movers: Intel jumps 9% on chip pact with Amazon
3M ago
BOX
AMZN
I-Mab Showcases Promising Gastric Cancer Drug Results
PremiumCompany Announcements
I-Mab Showcases Promising Gastric Cancer Drug Results
3M ago
6K
IMAB
I-Mab presents updated Phase 1 Givastomig data at ESMO
PremiumThe Fly
I-Mab presents updated Phase 1 Givastomig data at ESMO
3M ago
IMAB
I-Mab’s uliledlimab shows positive pharmacokinetics data in lung cancer
PremiumThe FlyI-Mab’s uliledlimab shows positive pharmacokinetics data in lung cancer
3M ago
IMAB
I-MAB Engages Interim CEO in Strategic Agreement
Premium
Company Announcements
I-MAB Engages Interim CEO in Strategic Agreement
4M ago
6K
IMAB
I-Mab Highlights Pipeline Success and Strong Finances
Premium
Company Announcements
I-Mab Highlights Pipeline Success and Strong Finances
4M ago
6K
IMAB
I-Mab Announces New Auditor for Strategic Growth
PremiumCompany Announcements
I-Mab Announces New Auditor for Strategic Growth
5M ago
6K
IMAB
I-Mab Announces Major Leadership Overhaul
PremiumCompany Announcements
I-Mab Announces Major Leadership Overhaul
5M ago
6K
IMAB
I-Mab announces leadership transitions
PremiumThe Fly
I-Mab announces leadership transitions
5M ago
IMAB
I-Mab Biopharma: Innovating Cancer Treatments
PremiumCompany Announcements
I-Mab Biopharma: Innovating Cancer Treatments
7M ago
6K
IMAB
I-Mab names Phillip Dennis, MD, PhD, as Chief Medical Officer
PremiumThe FlyI-Mab names Phillip Dennis, MD, PhD, as Chief Medical Officer
7M ago
SNY
IMAB
I-Mab and Bristol Myers Squibb Tackle Gastric Cancer
Premium
Company Announcements
I-Mab and Bristol Myers Squibb Tackle Gastric Cancer
7M ago
6K
IMAB
I-Mab announces clinical trial collaboration with Bristol Myers
Premium
The Fly
I-Mab announces clinical trial collaboration with Bristol Myers
7M ago
BMY
IMAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >